CELL CYCLE REGULATION IN CARDIOVASCULAR BIOLOGY
心血管生物学中的细胞周期调节
基本信息
- 批准号:6537519
- 负责人:
- 金额:$ 28.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-07-01 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Efforts to regenerate cardiac tissue by stimulating myocyte re- entry into the cell division cycle have been limited by the inability of postnatal cardiac myocytes to undergo mitosis. Co- expression of transcription factors active during G1 and S phase can induce exit from GO and DNA replication, however, these cells are blocked in G2. In lower eukaryotes, mitotic entry requires the coordinated expression of many genes, however, mechanisms controlling their transcription remain largely unknown. The characterization of transcriptional activators regulating G2/M transit would significantly advance our understanding of cell division and provide new therapeutic strategies for the regeneration of damaged myocardium. Our long-term goal is to understand the transcriptional regulation of cell division, and how such processes can be manipulated toward myocardial regeneration. Our current approach is to focus on the biology of hCdc5, a novel human phosphoprotein we cloned and demonstrated to be the first transcriptional regulator of G2/M described in mammalian cells. The proposed studies will address the mechanisms by which hCdc5 regulates the cell division cycle. Our specific aims are to: 1) determine the role of phosphorylation and nuclear import in regulating hCdc5 function by testing nuclear localization signal mutants for nuclear translocation, identifying specific phosphorylation sites by in vitro kinase assay and phosphopeptide mapping, and testing phosphorylation mutants for subcellular localization, transcriptional activity, and effects on G2/M; 2) identify associated proteins which regulate hCdc5 activity using affinity chromatography and a yeast two-hybrid screen; and 3) identify mammalian targets of hCdc5 by selection and amplification of targets, binding site selection in yeast, and cDNA subtraction. These studies will provide basic insights into transcriptional mechanisms for G2/M control as well as reagents for manipulating the cell cycle in non-dividing tissues.
通过刺激心肌细胞重新进入细胞分裂周期来再生心脏组织的努力受到出生后心肌细胞不能进行有丝分裂的限制。 在G1期和S期激活的转录因子的共表达可以诱导从GO退出和DNA复制,然而,这些细胞在G2期被阻断。 在低等真核生物中,有丝分裂进入需要许多基因的协调表达,然而,控制其转录的机制在很大程度上仍然未知。 对G2/M期转录激活因子的研究将极大地促进我们对细胞分裂的理解,并为受损心肌的再生提供新的治疗策略。 我们的长期目标是了解细胞分裂的转录调控,以及如何操纵这些过程实现心肌再生。 我们目前的方法是专注于hCdc 5的生物学,我们克隆了一种新的人类磷蛋白,并证明是哺乳动物细胞中描述的第一个G2/M转录调节因子。 拟议的研究将解决hCdc 5调节细胞分裂周期的机制。 我们的具体目标是:1)通过测试核定位信号突变体的核转位,通过体外激酶测定和磷酸肽作图鉴定特异性磷酸化位点,并测试磷酸化突变体的亚细胞定位、转录活性和对G2/M的影响,确定磷酸化和核输入在调节hCdc 5功能中的作用; 2)使用亲和层析和酵母双杂交筛选鉴定调节hCdc 5活性的相关蛋白;和3)通过靶的选择和扩增、酵母中的结合位点选择和cDNA消减来鉴定hCdc 5的哺乳动物靶。 这些研究将为G2/M控制的转录机制以及用于操纵非分裂组织中细胞周期的试剂提供基本见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAROLD S BERNSTEIN其他文献
HAROLD S BERNSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAROLD S BERNSTEIN', 18)}}的其他基金
PHOSPHORYLATION REGULATES HUMAN CDC5 FUNCTION
磷酸化调节人类 CDC5 功能
- 批准号:
7957368 - 财政年份:2009
- 资助金额:
$ 28.55万 - 项目类别:
PHOSPHORYLATION REGULATES HUMAN CDC5 FUNCTION
磷酸化调节人类 CDC5 功能
- 批准号:
7180943 - 财政年份:2005
- 资助金额:
$ 28.55万 - 项目类别:
PHOSPHORYLATION REGULATES HUMAN CDC5 FUNCTION
磷酸化调节人类 CDC5 功能
- 批准号:
6976633 - 财政年份:2004
- 资助金额:
$ 28.55万 - 项目类别:
CELL CYCLE REGULATION IN CARDIOVASCULAR BIOLOGY
心血管生物学中的细胞周期调节
- 批准号:
2806213 - 财政年份:1999
- 资助金额:
$ 28.55万 - 项目类别:
CELL CYCLE REGULATION IN CARDIOVASCULAR BIOLOGY
心血管生物学中的细胞周期调节
- 批准号:
6390248 - 财政年份:1999
- 资助金额:
$ 28.55万 - 项目类别:
CELL CYCLE REGULATION IN CARDIOVASCULAR BIOLOGY
心血管生物学中的细胞周期调节
- 批准号:
6604668 - 财政年份:1999
- 资助金额:
$ 28.55万 - 项目类别:
相似海外基金
Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
- 批准号:
24K15172 - 财政年份:2024
- 资助金额:
$ 28.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
- 批准号:
23K04928 - 财政年份:2023
- 资助金额:
$ 28.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
- 批准号:
10744934 - 财政年份:2023
- 资助金额:
$ 28.55万 - 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
- 批准号:
573688-2022 - 财政年份:2022
- 资助金额:
$ 28.55万 - 项目类别:
University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10704557 - 财政年份:2022
- 资助金额:
$ 28.55万 - 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10537846 - 财政年份:2022
- 资助金额:
$ 28.55万 - 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
- 批准号:
2753921 - 财政年份:2022
- 资助金额:
$ 28.55万 - 项目类别:
Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
- 批准号:
10328140 - 财政年份:2022
- 资助金额:
$ 28.55万 - 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
- 批准号:
10621368 - 财政年份:2021
- 资助金额:
$ 28.55万 - 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
- 批准号:
2111821 - 财政年份:2021
- 资助金额:
$ 28.55万 - 项目类别:
Standard Grant